Compounds > parthenolide

parthenolide and Carcinoma

parthenolide has been researched along with Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HF; Gao, YF; He, CY; Hou, MJ; Huang, YJ; Li, XJ; Liao, K; Lin, YC; Lin, ZN; Ling, WH; Luo, B; Qiu, Y; Xia, B; Zhang, YJ; Zhuang, QY1
Cheng, G; Xie, L1
Marshall, MS; Nakshatri, H; Schmidt, CM; Sweeney, CJ; Wiebke, EA; Yip-Schneider, MT1

Other Studies

3 other study(ies) available for parthenolide and Carcinoma

ArticleYear
Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway.
    Theranostics, 2015, Volume: 5, Issue:3

    Topics: Antineoplastic Agents; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Gene Expression Profiling; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; NF-kappa B; Real-Time Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction

2015
Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
    Molecules (Basel, Switzerland), 2011, Aug-09, Volume: 16, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 2; Diffusion Chambers, Culture; Flow Cytometry; G1 Phase; Humans; Microscopy; Neoplasm Invasiveness; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Signal Transduction; Tanacetum parthenium; Urinary Bladder Neoplasms

2011
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Humans; Models, Biological; NF-kappa B; Pancreatic Neoplasms; Phosphorylation; Protein Binding; Sesquiterpenes; Sulindac; Transcription, Genetic; Transfection

2005